Healthcare Unusual Volume: LDR Holding (NASDAQ:LDRH), Addus Homecare Corporation (NASDAQ:ADUS), Actinium Pharmaceuticals (NYSEMKT:ATNM), Relypsa (NASDAQ:RLYP)

Austin-based medical device company LDR Holding Corp. (NASDAQ:LDRH) is aiming to raise up to $23 million with a follow-on stock offering, according to documents filed Friday with the U.S. Securities and Exchange Commission. LDR Holding Corp (NASDAQ:LDRH) shares after opening at $24.03 moved to $24.82 on last trade day and at the end of the day closed at $24.07. Company price to sales ratio in past twelve months was calculated as 5.19 and price to cash ratio as 10.22. LDR Holding Corp (NASDAQ:LDRH) showed a negative weekly performance of -14.71%.

Addus HomeCare Corporation (NASDAQ:ADUS), a comprehensive provider of home and community based services focused primarily on the dual eligible population, announced that it will release earnings for the first quarter ended March 31, 2014 on Thursday, May 1, 2014 after the market close. Addus Homecare Corporation (NASDAQ:ADUS) shares fell -5.24% in last trading session and ended the day on $20.27. ADUS return on equity ratio is recorded as 17.30% and its return on assets is 12.20%. Addus Homecare Corporation (NASDAQ:ADUS) yearly performance is 68.36%.

Actinium Pharmaceuticals Inc. (NYSEMKT:ATNM) a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers announced that its shares have commenced trading on the NYSE MKT under the symbol “ATNM”. Actinium Pharmaceuticals Inc. (NYSEMKT:ATNM) shares moved up 0.00% in last trading session and was closed at $12.30, while trading in range of $11.25 – $12.30. Actinium Pharmaceuticals Inc. (NYSEMKT:ATNM) year to date (YTD) performance is 108.83%.

Relypsa Inc. (NASDAQ:RLYP), a biopharmaceutical company, announced that it has priced an underwritten public offering of about 3.59 million shares of its common stock at a price to the public of $24.50 per share for gross proceeds of about $88 million. Relypsa Inc. (NASDAQ:RLYP) weekly performance is -0.88%. On last trading day company shares ended up $24.82. Relypsa Inc. (NASDAQ:RLYP) distance from 50-day simple moving average (SMA50) is -32.04%. Analysts mean target price for the company is $54.00.